Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

Adrenal Gland Disorders

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...

Hormonal Regulation

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.

Renal Tubule and Collecting Duct

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations.

European journal of human genetics : EJHG·2020

Same author

Molecular pathogenesis of renal pseudohypoaldosteronism type 1.

Expert review of endocrinology & metabolism·2019

Same author

Gonadotropin- and Adrenocorticotropic Hormone-Independent Precocious Puberty of Gonadal Origin in a Patient with Adrenal Hypoplasia Congenita Due to DAX1 Gene Mutation - A Case Report and Review of the Literature: Implications for the Pathomechanism.

Hormone research in paediatrics·2018

Same author

In vivo investigations of the effect of short- and long-term recombinant growth hormone treatment on DNA-methylation in humans.

PloS one·2015

Same author

46,XY disorder of sex development in a sudanese patient caused by a novel mutation in the HSD17B3 gene.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation·2014

Same author

17α-hydroxylase deficiency diagnosed in early infancy caused by a novel mutation of the CYP17A1 gene.

Hormone research in paediatrics·2014

Same journal

Transition in Pediatric and Adolescent Hypogonadal Girls: Gynecological Aspects, Estrogen Replacement Therapy, and Contraception.

Endocrine development·2018

Same journal

Transition of Care from Childhood to Adulthood: Congenital Hypogonadotropic Hypogonadism.

Endocrine development·2018

Same journal

Management of Hypothalamic Obesity during Transition from Childhood to Adulthood.

Endocrine development·2018

Same journal

Fertility Preservation in Endocrine Disorders during Transition for Girls.

Endocrine development·2018

Same journal

Transition of Care from Childhood to Adulthood: Turner Syndrome.

Endocrine development·2018

Same journal

Transitions in Care from Pediatric to Adult Health Care Providers: Ongoing Challenges and Opportunities for Young Persons with Diabetes.

Endocrine development·2018

See all related articles

Search research articles

Related Experiment Video

Updated: May 14, 2026

A Novel Method: Super-selective Adrenal Venous Sampling

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Pseudohypoaldosteronism.

Felix G Riepe¹

¹Division of Pediatric Endocrinology, Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany. friepe@pediatrics.uni-kiel.de

Endocrine Development

|February 9, 2013

Summary

This summary is machine-generated.

Pseudohypoaldosteronism (PHA) involves mineralocorticoid resistance. PHA1 presents as systemic or renal forms, while PHA2 causes hypertension and PHA3 involves transient salt loss.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

Related Experiment Videos

Last Updated: May 14, 2026

A Novel Method: Super-selective Adrenal Venous Sampling

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

Area of Science:

Endocrinology
Genetics
Pediatrics

Background:

Pseudohypoaldosteronism (PHA) is a rare endocrine disorder characterized by mineralocorticoid resistance.
PHA is classified into types 1, 2, and 3, each with distinct genetic causes and clinical presentations.

Purpose of the Study:

To summarize the different types of Pseudohypoaldosteronism (PHA).
To outline the genetic basis and clinical manifestations of PHA types 1, 2, and 3.

Main Methods:

Literature review of Pseudohypoaldosteronism (PHA) classifications.
Analysis of genetic mutations and clinical phenotypes associated with PHA types.

Main Results:

PHA type 1 (PHA1) includes systemic (ENaC gene mutations) and renal (NR3C2 gene mutations) forms, presenting with dehydration, hyponatremia, hyperkalemia, and elevated renin/aldosterone.
PHA type 2 (PHA2) is defined by hyperkalemia, hypertension, metabolic acidosis, and variable aldosterone levels.
PHA type 3 (PHA3) involves transient salt-losing states, often secondary to urinary tract pathologies, with decreased glomerular filtration rate.

Conclusions:

PHA encompasses diverse conditions of mineralocorticoid resistance with distinct genetic underpinnings and clinical outcomes.
Understanding the specific PHA type is crucial for diagnosis and management, particularly in infants.
Further research into the molecular mechanisms and therapeutic strategies for PHA is warranted.